Stemformula is a San Diego-based joint-venture between Genautica and Imgenex India working on optimizing the generation of nanovesicle-encapsulated transcription factors for the specific de- and re-differentiation of primary cells in-vitro as well as in-vivo. This technology avoids the use of plasmids or viral vectors to create or manipulate adult and embryonic stem cells and their derivatives.